Australia  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Imugene begins manufacture of its innovative cancer vaccine for trials

Proactive Investors Sunday, 23 September 2018
Imugene Limited (ASX:IMU) has formally commenced cGMP (current good manufacturing practice) manufacture of the clinical batch of its cancer vaccine KEY-Vaxx. The cGMP batch is part of the pre-clinical development for the proposed PD-1 phase I clinical trial to be conducted in 2019. AmbioPharm Inc, a US-based peptide manufacturing company has been appointed to manufacture the vaccine. We've commenced cGMP manufacturing of the clinical batch of cancer vaccine KEY-Vaxx for the proposed Phase 1 PD-1 clinical trial, after successfully completing pilot studies. AmbioPharm Inc. (APi), a US-based cGMP manufacturer has been appointed $IMU #ASX https://t.co/xL390CKopH pic.twitter.com/YVOYROEtbZ — Imugene Ltd (@TeamImugene) September 20, 2018 KEY-Vaxx is a B-cell peptide cancer vaccine which aims to induce the body to produce polyclonal antibodies that block PD-1 signalling, and potentially produce an anticancer effect similar to Keytruda, Opdivo and the other immune checkpoint inhibitor monoclonal antibodies that are transforming the treatment of a range of cancers. KEY-Vaxx has shown potential in preclinical studies, outperforming an industry-standard antibody in a mouse model of HER2+ colorectal cancer. New provisional patent The protection of Imugene’s global position in PD-1 B-cell cancer vaccines has been strengthened with the filing of a new provisional patent in Australia titled “A vaccine composition and uses thereof”. READ: Imugene signs exclusive, world-widelicence for cancer vaccine Imugene managing director Leslie Chong said: “Maintaining and strengthening our already strong international intellectual property position is a key area of focus in maintaining the competitive advantage of KEY-Vaxx and any future improvements, vaccine formulations and clinical uses. “We are extremely pleased with the progress made from our expert scientific team.”
0
shares
ShareTweetSavePostSend
 
Credit: Seeker - Published < > Embed
News video: What Happens When CRISPR Backfires?

▶ What Happens When CRISPR Backfires? 03:26

Ever since it was introduced in 2013, CRISPR has been touted as a promising technology for treating inherited disorders, cancer, and other diseases with no current treatment options. Teams of researchers had been hoping to begin human trials in 2018, but none of those trials have taken place yet with...

Recent related videos from verified sources

New Study: Drinking Piping Hot Tea Almost Doubles Risk of Cancer [Video]New Study: Drinking Piping Hot Tea Almost Doubles Risk of Cancer

A new study now says that piping hot cup of tea could put you at risk for throat cancer. Nathan Rousseau Smith has the details.

Credit: Veuer     Duration: 01:21Published

Ring My Bell: Woman Celebrates After Cancer All-Clear [Video]Ring My Bell: Woman Celebrates After Cancer All-Clear

Lakesha Ball celebrated joyfully as she rang the “Hope Bell” at Maryland Proton Treatment Center, signifying the end of her cancer treatment.Ball rang the bell after her final radiation..

Credit: Storyful Studio     Duration: 00:45Published

Study Finds Link Between Drinking Hot Tea And Esophageal Cancer [Video]Study Finds Link Between Drinking Hot Tea And Esophageal Cancer

According to UPI, those who like drinking hot tea might want to wait until it gets cooler before taking that first sip. Drinking more than 700ML of tea at higher than 140 degrees Fahrenheit, was linked..

Credit: Wochit News     Duration: 00:33Published

Colon Cancer Can Be Deadly But It is The Most Preventable [Video]Colon Cancer Can Be Deadly But It is The Most Preventable

Colon Cancer Can Be Deadly But It is The Most Preventable. Follow these tips to start on the path of preventing possible future colon cancer.

Credit: FOX 47 News Michigan     Duration: 01:18Published

7Everyday Hero Kristi Card knits hats for kids battling cancer [Video]7Everyday Hero Kristi Card knits hats for kids battling cancer

Sitting in her living room, Kristi Card is knitting the knots of compassion all for some of cancer's tiniest fighters. The Littleton woman began knitting and selling scarves years ago after losing her..

Credit: 7News - The Denver Channel     Duration: 02:20Published

ESPN Uses Events To Raise Money For Cancer [Video]ESPN Uses Events To Raise Money For Cancer

ESPN is using many of their popular events to raise money for cancer. Broadcasting & Cable reports that the ESPY Awards have generated over than $97 million dollars for cancer research. The annual..

Credit: Wochit     Duration: 00:39Published

'Jeopardy!' Host Alex Trebek Thanks Fans For Outpouring Of Support [Video]'Jeopardy!' Host Alex Trebek Thanks Fans For Outpouring Of Support

The outpouring of support toward Alex Trebek has not gone unnoticed by the long-time "Jeopardy!" host. On Thursday, Trebek thanked the “hundreds of thousands of people” who have wished him well..

Credit: Wochit Entertainment     Duration: 01:05Published

Alex Trebek Is Back On Jeopardy [Video]Alex Trebek Is Back On Jeopardy

We can't wait to watch him. Get Well Alex. We are all praying for you.

Credit: Celebrity Wire     Duration: 01:10Published

Alex Trebek Returns to 'Jeopardy!' After Announcing Cancer Diagnosis [Video]Alex Trebek Returns to 'Jeopardy!' After Announcing Cancer Diagnosis

Alex Trebek Returns to 'Jeopardy!' After Announcing Cancer Diagnosis The longtime host recently made a video announcement and revealed he has stage 4 pancreatic cancer. Only one week after announcing..

Credit: Wibbitz Studio     Duration: 01:10Published

Cancer Center In Colorado Offering Some Hope For Older Cancer Patients [Video]Cancer Center In Colorado Offering Some Hope For Older Cancer Patients

Doctors believe a new treatment, studied at the University of Colorado Cancer Center, may be a cure.

Credit: CBS 4 Denver     Duration: 02:22Published


Recent related news from verified sources

Imugene doses milestone first patient for cancer vaccine trial

Imugene Ltd (ASX:IMU) has dosed its first patient in its phase II study with its HER-Vaxx (IMU-131) cancer vaccine for the treatment of HER-2 positive gastric...
Proactive Investors

Imugene obtains FDA guidance for KEY-Vaxx immunotherapy clinical development plan

Imugene Ltd (ASX:IMU) managing director & CEO Leslie Chong updates Proactive Investors on the clinical-stage immuno-oncology company’s development of its...
Proactive Investors

Chinese HEV vaccine to begin clinical trial in U.S.

Chinese HEV vaccine to begin clinical trial in U.S.
XIAMEN, March 22 (Xinhua) -- A Chinese vaccine against the Hepatitis E Virus (HEV) has been approved by the U.S. Food and Drug Administration (FDA) to enter...
WorldNews

You Might Like


Tweets about this


Other recent news in Business

Vic SALMONELLA egg scare linked to NSWGalena Mining secures $10 MILLION investment from Kingfisher Capital
Anatara Lifesciences transitions gut HEALTH focus from animals to humansFive NSW ELECTION issues that matter
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.